AEZS AEterna Zentaris Inc
- 8.000
- 0.0000.00%
AEterna Zentaris Inc News
Aeterna Zentaris Completes Phase 3 DETECT-Trial For Macimorelin In Diagnosing Childhood Onset Growth Hormone Deficiency; Top-Line Data And Full Study Results Expected In Q3 2024
Aeterna Zentaris Completes Phase 3 DETECT-Trial For Macimorelin In Diagnosing Childhood Onset Growth Hormone Deficiency; Top-Line Data And Full Study Results Expected In Q3 2024
News On Ceapro Inc. (CZO.V) Now Under AEZS.T
News On Ceapro Inc. (CZO.V) Now Under AEZS.T
Shareholder Alert: Ademi LLP Investigates Whether Aeterna Zentaris Inc.'s Transaction With Ceapro Was Fair to Shareholders
MILWAUKEE, June 7, 2024 /PRNewswire/ -- Ademi LLP is investigating Aeterna (Nasdaq: AEZS) for possible breaches of fiduciary duty and other violations of law in its transaction with Ceapro. Click her
Aeterna and Ceapro Brief: Cos Complete Merger Transaction; New Name Expected to Be Announced in Coming Weeks and Details of AGM Expected to Be Announced Shortly
09:25 AM EDT, 06/03/2024 (MT Newswires) -- Aeterna and Ceapro Brief: Cos Complete Merger Transaction; New Name Expected to be Announced in Coming Weeks and Details of AGM Expected to be Announced Shor
Aeterna Zentaris and Ceapro Complete Merger Transaction
Aeterna Zentaris and Ceapro Complete Merger Transaction
Aeterna Zentaris Seeks Meeting Delay for Merger
Canada Net Change Percentage Gainers & Losers
GAINERS COMPANY SYMBOL LAST CHANGE PERCENT VOLUME ------- ------ ---- ------ ------- ------ AEterna Ze
Ceapro's Q1 Net Loss Swells YoY, But Talks Up Benefits of Planned Aeterna Merger
Ceapro (CZO.V), in the process of merging with Aeterna Zentaris Inc. (NASDAQ and TSX: AEZS), said Wednesday that its net loss in the first quarter swelled year over year. But it expects the return of
Cancer Cachexia Pipeline Insights Report, 2024 Featuring Emerging Drugs Macimorelin (AEterna Zentaris) and PF-06946860 (Pfizer)
Aeterna and Ceapro Brief: Aeterna Zentaris Announcing Details Regarding Transaction With Ceapro
08:01 AM EDT, 05/17/2024 (MT Newswires) -- Aeterna and Ceapro Brief: Aeterna Zentaris Announcing Details Regarding Transaction with Ceapro
Aeterna Zentaris Announces Details Regarding Transaction With Ceapro
The Toronto Stock Exchange and Nasdaq have determined that the Common Shares will trade on a due bill basis from the opening of markets on May 29, 2024 to the Payment Date (i.e., May 31, 2024), inclusive.
Aeterna Zentaris Reports Q1 Financial Dip
AEterna Zentaris | 6-K: Report of foreign private issuer (related to financial reporting)
Aeterna Zentaris: Q1 Results and Upcoming Merger
Aeterna Zentaris Gains Key Accounting Consent
MT Newswires Canada Overnight Stocks To Watch: Aeterna Zentaris; Orla Mining; Andlauer Healthcare; CES Energy Solutions; Imperial Metals; Sulliden
Aeterna Zentaris Inc. (NASDAQ and TSX: AEZS) , a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, overnight Tuesday
Aeterna Zentaris: Strong Cash Reserve Amidst Upcoming Merger
AEterna Zentaris Q1 2024 GAAP EPS $(4.74) Vs. $(3.51) Last Year
AEterna Zentaris (NASDAQ:AEZS) reported quarterly losses of $(4.74) per share which missed the analyst consensus estimate of $(0.81) by 485.19 percent. This is a 35.04 percent decrease over losses of
Aeterna Zentaris Reports First Quarter 2024 Financial Results
Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) today reported its financial and operating results for the quarter ended March 31, 2024.
Aeterna Zentaris Sets Date for Virtual Shareholders Meeting
